Development Committee Meetings. During the term of this Agreement, the Development Committee shall meet every two months, or more often as agreed by the parties, in Houston, Texas, or such other location as the parties agree. The parties agree that at least two (2) meetings of the Development Committee per full calendar year will be held at RPRP's facilities. At its meetings, the Development Committee will (i) formulate and review the Early Stage Development Program objectives, (ii) monitor the progress of the Early Stage Development Program toward those objectives, (iii) review and approve the Program Plan and Budget, and Product Plans and Budgets, pursuant to Section 3.4 of this Agreement, and (iv) monitor the progress of both Early Stage Development and Later Stage Clinical Development. With the consent of the parties, other representatives of Introgen or RPRP or their Affiliates or Sublicensees, may attend Development Committee meetings as non-voting observers. With respect to matters relating to Early Stage Development, Introgen's lead representative shall chair meetings of the Development Committee, and with respect to matters relating to Later Stage Clinical Development, RPRP's lead representative shall chair such meetings. The party whose representatives chair a meeting with respect to particular matters shall be responsible for preparing the agenda and minutes for such meetings.
Appears in 4 contracts
Samples: Collaboration Agreement (Introgen Therapeutics Inc), Collaboration Agreement (Introgen Therapeutics Inc), Collaboration Agreement (Introgen Therapeutics Inc)